愛德華茲 EW 深 滬
已收盤 01-09 16:00:00 美东时间
85.13
+0.550
+0.65%
華盛通- 最 高86.05
- 今 開85.275
- 成交量 338.39万股
- 最 低 84.72
- 昨 收 84.58
- 總市值 499.71亿
- 52周最高 87.89
- 市盈率 靜 58.33
- 換手率 0.58%
- 52周最低 65.94
- 委 比 -56.62%
- 總股本 5.87亿
- 歷史最高 131.73
- 量 比 0.92
- 振 幅 1.57%
- 歷史最低 10.1033
- 每 手 1
- 風險率 5.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
<p>RxSight, Inc. reported preliminary unaudited Q4 and full-year 2025 financial results, with Q4 revenue of approximately $32.6 million and full-year revenue of $134.5 million, exceeding November guidance. The company sold 28,611 LALs and 25 LDDs in Q4, and 109,615 LALs and 163 LDDs in 2025, reflecting a 10% and 12% procedure volume increase respectively. Cash, cash equivalents, and short-term investments totaled $228.1 million as of December 31,...
01-11 14:30
快讯 | 法官批准了美国联邦贸易委员会阻止爱德华生命科学收购Jenavalve Technology Inc的请求——法院记录
Judge Grants U.S. Federal Trade Commission Request to Block Edwards Lifescience...
01-10 05:08
Goldman’s best fundamental ideas with upside to estimates on upcoming earnings season
Goldman Sachs Research has identified its top fundamental opportunities with expected upside from estimates, highlighting stocks where analysts see significant upside to consensus estimates heading in...
01-09 02:47
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
Stifel Maintains Buy on Edwards Lifesciences, Raises Price Target to $105
Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $100 to $105.
01-07 22:16
LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation
LifeVantage appoints Mike Edwards as Chief Technology Officer, leveraging his 25 years of experience to drive digital transformation and enhance technology solutions. Edwards, known for enterprise-wide technology initiatives, will focus on scaling infrastructure, improving customer experiences, and supporting the company's growth strategy. LifeVantage, a leader in nutrigenomics, offers products designed to activate cellular health and operates a ...
01-07 21:05
BTIG’s 2026 top picks report spotlights 21 large-cap stocks to watch
BTIG’s Top Picks report brings together the firm’s highest-conviction investment ideas drawn from its research platform, with a 12-month investment horizon beginning in the first half of 2026. As the ...
01-02 21:21
Edwards Lifesciences Says FDA Approves SAPIEN M3 Mitral Valve Replacement System For Treatment Of Mitral Regurgitation
Edwards Lifesciences (NYSE:EW) today announced the company's SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach to receive U.S. Food and Drug Administration
2025-12-23 22:03
Wall Street Got Smoked By These 20 Stock Markets In 2025
Global equity markets crushed Wall Street in 2025 as South Korea, Peru and Europe posted massive gains, far outpacing the S&P 500.
2025-12-19 23:47
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
